Skip to content

Pilot Study to Evaluate the Clinical Utility of Auscultation Software at Remote Locations

Pilot Study to Evaluate the Clinical Utility of 3M Littmann Scope-to-Scope Software for Real-time Assessment of Patients at Remote Clinic Locations by Centrally-located Medical Providers

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01138592
Enrollment
150
Registered
2010-06-07
Start date
2010-06-30
Completion date
2011-01-31
Last updated
2024-10-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Auscultation of Heart and Lungs

Brief summary

Primary Objective: Evaluation of the utility of real-time, scope-to-scope communication between commercially-available 3M Littmann Electronic Model 3200 Electronic stethoscopes over a dedicated intranet system for the assessment of patients at remote (satellite) clinic locations by centrally-located (hub) medical providers. Secondary Objective: Comparison of the accuracy of patient assessment between the remotely located, mid-level presenter with the centrally-located physician or nurse practitioner provider.

Interventions

None listed

Sponsors

3M
CollaboratorINDUSTRY
Solventum US LLC
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Male and female subjects who are at least 18 years of age 2. Subjects who are scheduled to undergo examination in a telemedicine setting 3. Subjects who are willing to voluntarily sign the compound Informed Consent and the Authorization to Disclose Protected Health Information Form.

Exclusion criteria

1. Subjects who are unwilling to undergo additional examination in a telemedicine setting, 2. Any subject requiring time-critical medical intervention. 3. Any subject who the investigator believes should not be included or is unsuitable for inclusion in the study.

Design outcomes

Primary

MeasureTime frameDescription
Confirmation of hub (remote) observations with satellite (local) observations30 minutesPresence or absence of heart or lung sound; e.g., murmurs, etc., and/or rales, rhonchii, wheezes.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026